Market Overview:
The global valve bioprostheses market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in valve bioprostheses, and rising demand for minimally invasive surgeries. Based on type, the global valve bioprostheses market is segmented into aortic, mitral, pulmonary, and tricuspid valves. The aortic valves segment is expected to account for the largest share of the global market in 2018. This can be attributed to the increasing incidence of aortic stenosis and other heart diseases that require replacement or repair of an aortic valve. Based on application, the global valve bioprostheses market is segmented into hospitals, clinics, and others (including research institutes and academic medical centers).
Product Definition:
A valve bioprosthesis is a medical device made from animal or human tissue that is implanted in the body to replace a heart valve. The most common type of valve bioprosthesis used in humans is a cow's heart valve that has been treated with chemicals to kill any viruses or bacteria.
Aortic:
The aortic valve is the largest blood vessel in the body and it's main function is to control the flow of blood from the heart to all other organs, tissues and veins. Aortic stenosis or a large aortic valve opening (aV/A) is one of the most common cardiovascular diseases that affects around 7.5 million people in Europe, America, Japan and Australia each year.
Mitral:
The mitral valve is a heart valve that controls the flow of blood through the heart. It is a two-leaflet structure, which separates blood entering and leaving the left atrium from returning to the right atrium. The function of this valve is to prevent blood from backing up in case there are problems with its seating or if it were to get diseased.
Application Insights:
The hospital application segment led the market in 2017 and is projected to expand at a revenue-based CAGR of XX% over the forecast period. Increasing number of valve replacement surgeries coupled with rising prevalence of cardiovascular diseases is expected to drive growth in hospital applications over the coming years. Moreover, increasing R&D investments by various companies for developing advanced products for use in hospitals will further boost industry growth.
Clinic applications include self-operated or minimally invasive surgeries, which involve lesser recovery time and shorter hospital stays as compared to conventional open heart surgery procedures. Growing awareness about availability of advanced treatment facilities along with growing preference towards outpatient surgical procedures are some factors anticipated to propel demand from clinics over the coming years.
Other applications include home healthcare.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high adoption rate of advanced technologies, and favorable reimbursement policies are some factors driving the regional growth. Moreover, increasing geriatric population prone to cardiac diseases is anticipated to fuel market growth over the forecast period.
Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to rising patient awareness levels regarding valve replacement surgeries coupled with growing medical tourism industry in emerging countries such as China and India. In addition, booming cardiovascular disease (CVD) care sector due to government initiatives for improving public health systems will drive demand for valve bioprosthesis products over next eight years.
Growth Factors:
- Increasing prevalence of cardiovascular diseases (CVDs) is expected to drive the demand for valve bioprostheses over the forecast period.
- Rising geriatric population is also anticipated to boost the market growth as this population is more susceptible to CVDs.
- Technological advancements in valve bioprostheses are likely to propel the market growth in coming years.
- Growing preference for minimally invasive surgeries is projected to fuel the demand for valve bioprostheses over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Valve Bioprostheses Market Research Report
By Type
Aortic, Mitral, Pulmonary, Tricuspid
By Application
Hospital, Clinic, Others
By Companies
Braile Biomedica, Colibri Heart Valve, Edwards Lifesciences, JenaValve, Labcor, Meril Life Sciences, pulmonX, LivaNova, Valtech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Valve Bioprostheses Market Report Segments:
The global Valve Bioprostheses market is segmented on the basis of:
Types
Aortic, Mitral, Pulmonary, Tricuspid
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Braile Biomedica
- Colibri Heart Valve
- Edwards Lifesciences
- JenaValve
- Labcor
- Meril Life Sciences
- pulmonX
- LivaNova
- Valtech
Highlights of The Valve Bioprostheses Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Aortic
- Mitral
- Pulmonary
- Tricuspid
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Valve Bioprostheses Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Valve Bioprostheses are a type of artificial heart valve that helps to improve the quality of life for people with heart disease. These valves can help to reduce the amount of time that someone needs to spend in hospital, and may also help them avoid surgery altogether.
Some of the major companies in the valve bioprostheses market are Braile Biomedica, Colibri Heart Valve, Edwards Lifesciences, JenaValve, Labcor, Meril Life Sciences, pulmonX, LivaNova, Valtech.
The valve bioprostheses market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Valve Bioprostheses Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Valve Bioprostheses Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Valve Bioprostheses Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Valve Bioprostheses Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Valve Bioprostheses Market Size & Forecast, 2018-2028
4.5.1 Valve Bioprostheses Market Size and Y-o-Y Growth
4.5.2 Valve Bioprostheses Market Absolute $ Opportunity
Chapter 5 Global Valve Bioprostheses Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Valve Bioprostheses Market Size Forecast by Type
5.2.1 Aortic
5.2.2 Mitral
5.2.3 Pulmonary
5.2.4 Tricuspid
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Valve Bioprostheses Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Valve Bioprostheses Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Valve Bioprostheses Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Valve Bioprostheses Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Valve Bioprostheses Analysis and Forecast
9.1 Introduction
9.2 North America Valve Bioprostheses Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Valve Bioprostheses Market Size Forecast by Type
9.6.1 Aortic
9.6.2 Mitral
9.6.3 Pulmonary
9.6.4 Tricuspid
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Valve Bioprostheses Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Valve Bioprostheses Analysis and Forecast
10.1 Introduction
10.2 Europe Valve Bioprostheses Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Valve Bioprostheses Market Size Forecast by Type
10.6.1 Aortic
10.6.2 Mitral
10.6.3 Pulmonary
10.6.4 Tricuspid
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Valve Bioprostheses Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Valve Bioprostheses Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Valve Bioprostheses Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Valve Bioprostheses Market Size Forecast by Type
11.6.1 Aortic
11.6.2 Mitral
11.6.3 Pulmonary
11.6.4 Tricuspid
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Valve Bioprostheses Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Valve Bioprostheses Analysis and Forecast
12.1 Introduction
12.2 Latin America Valve Bioprostheses Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Valve Bioprostheses Market Size Forecast by Type
12.6.1 Aortic
12.6.2 Mitral
12.6.3 Pulmonary
12.6.4 Tricuspid
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Valve Bioprostheses Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Valve Bioprostheses Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Valve Bioprostheses Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Valve Bioprostheses Market Size Forecast by Type
13.6.1 Aortic
13.6.2 Mitral
13.6.3 Pulmonary
13.6.4 Tricuspid
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Valve Bioprostheses Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Valve Bioprostheses Market: Competitive Dashboard
14.2 Global Valve Bioprostheses Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Braile Biomedica
14.3.2 Colibri Heart Valve
14.3.3 Edwards Lifesciences
14.3.4 JenaValve
14.3.5 Labcor
14.3.6 Meril Life Sciences
14.3.7 pulmonX
14.3.8 LivaNova
14.3.9 Valtech
